Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine.
The ACIP will meet on Friday to discuss final approval. The Ohio Department of Health will then provide guidance. It is expected the booster for ages 5-11 could be available at the health department as early as next week. We will be sure to provide an update when it is available.
Original source can be found here
Alerts Sign-up